ASHLAND INC.
ASHNYSE
$68.64
↓ -0.2%Jul 17 close · end-of-day
Price
1Y↑ +38.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$3,157.44
Enterprise Value
$1.0B
P/E
—
P/S
0.0
P/B
0.0
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
241.8%
Revenue (TTM)
$1.8B
Net Income (TTM)
—
Free Cash Flow (TTM)
—
Gross Margin
30.0%
Operating Margin
-34.0%
Net Margin
—
ROE
—
ROIC
-16.7%
Debt / Equity
0.7
Net Cash
-$1.0B
Return 1Y
+34.9%
Company profile
Ashland Global Holdings Inc. provides additives and specialty ingredients. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders.
- CEO
- Guillermo Novo
- Sector
- Wholesale Trade
- Industry
- Wholesale
- Employees
- 3,900
- Headquarters
- Delaware
- Website
- ashland.com
Management & directors
- Minicucci James P.SVP and GM, Personal Care
- Drury EileenSVP and Chief HRO
- Lampkin Robin E.SVP, Gen Counsel and Secrty.
- Musa Osama MSVP and CTO
- Novo GuillermoChair of the Board and CEO
- Richardson SamuelVP, Controller and PAO
- Whitaker WilliamSVP, CFO & PFO
- Assis Alessandra FaccinSVP and GM, Life Sciences
- Caceres DagoSVP & GM, Specialty Additives
Roles derived from SEC Form 4 filings.
Earnings
ASH Q2 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$482.0M↑ +0.6%
Diluted EPS$0.34↓ -47.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.0B | $2.1B | $2.4B | $2.2B | $2.1B | $1.8B |
| Gross profit | $599.0M | $670.0M | $830.0M | $668.0M | $618.0M | $549.0M |
| Operating income | -$461.0M | $192.0M | $333.0M | $172.0M | -$26.0M | -$775.0M |
| Net income | — | — | — | — | — | — |
| Diluted EPS | -$8.39 | $3.59 | $16.41 | $3.31 | $3.36 | -$18.23 |
| Operating cash flow | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 29.7% | 31.7% | 34.7% | 30.5% | 29.2% | 30.1% |
| Operating margin | -22.9% | 9.1% | 13.9% | 7.9% | -1.2% | -42.5% |
| Net margin | — | — | — | — | — | — |
| Line item | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $544.0M | $521.0M | $405.0M | $479.0M | $463.0M | $477.0M | $386.0M | $482.0M |
| Gross profit | $186.0M | $173.0M | $111.0M | $147.0M | $132.0M | $159.0M | $105.0M | $147.0M |
| Operating income | -$61.0M | $32.0M | -$179.0M | $51.0M | -$708.0M | $61.0M | -$6.0M | $39.0M |
| Net income | — | — | — | — | — | — | — | — |
| Diluted EPS | $0.12 | $0.34 | -$3.50 | $0.65 | -$16.21 | $0.83 | -$0.26 | $0.34 |
| Operating cash flow | — | — | — | — | — | — | — | — |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 34.2% | 33.2% | 27.4% | 30.7% | 28.5% | 33.3% | 27.2% | 30.5% |
| Operating margin | -11.2% | 6.1% | -44.2% | 10.6% | -152.9% | 12.8% | -1.6% | 8.1% |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-08 | MINICUCCI JAMES P.· SVP and GM, Personal Care | Option exercise | 4,310 | $55.01 | $237,093.10 | filing |
| 2026-05-08 | MINICUCCI JAMES P.· SVP and GM, Personal Care | Tax withholding | 1,346 | $55.01 | $74,043.46 | filing |
| 2026-01-21 | Kulkarni Ashish K | Option exercise | 2,113 | $0.00 | $0.00 | filing |
| 2025-11-17 | NOVO GUILLERMO· Chair of the Board and CEO | Option exercise | 6,122 | $49.60 | $303,651.20 | filing |
| 2025-11-17 | NOVO GUILLERMO· Chair of the Board and CEO | Tax withholding | 2,563 | $49.60 | $127,124.80 | filing |
| 2025-11-17 | MUSA OSAMA M· SVP and CTO | Option exercise | 976 | $49.60 | $48,409.60 | filing |
| 2025-11-17 | Drury Eileen· SVP and Chief HRO | Option exercise | 567 | $49.60 | $28,123.20 | filing |
| 2025-11-17 | MUSA OSAMA M· SVP and CTO | Tax withholding | 335 | $49.60 | $16,616.00 | filing |
| 2025-11-17 | Drury Eileen· SVP and Chief HRO | Tax withholding | 280 | $49.60 | $13,888.00 | filing |
| 2025-11-17 | LAMPKIN ROBIN E.· SVP, Gen Counsel and Secrty. | Option exercise | 239 | $49.60 | $11,854.40 | filing |
| 2025-11-17 | RICHARDSON SAMUEL· VP, Controller and PAO | Option exercise | 107 | $49.60 | $5,307.20 | filing |
| 2025-11-17 | WHITAKER WILLIAM· SVP, CFO & PFO | Option exercise | 107 | $49.60 | $5,307.20 | filing |
| 2025-11-17 | LAMPKIN ROBIN E.· SVP, Gen Counsel and Secrty. | Tax withholding | 72 | $49.60 | $3,571.20 | filing |
| 2025-11-17 | WHITAKER WILLIAM· SVP, CFO & PFO | Tax withholding | 33 | $49.60 | $1,636.80 | filing |
| 2025-11-17 | RICHARDSON SAMUEL· VP, Controller and PAO | Tax withholding | 32 | $49.60 | $1,587.20 | filing |
| 2025-11-14 | NOVO GUILLERMO· Chair of the Board and CEO | Option exercise | 9,119 | $51.51 | $469,719.69 | filing |
| 2025-11-14 | NOVO GUILLERMO· Chair of the Board and CEO | Tax withholding | 3,817 | $51.51 | $196,613.67 | filing |
| 2025-11-14 | MUSA OSAMA M· SVP and CTO | Option exercise | 2,091 | $51.51 | $107,707.41 | filing |
| 2025-11-14 | Drury Eileen· SVP and Chief HRO | Option exercise | 1,297 | $51.51 | $66,808.47 | filing |
| 2025-11-14 | LAMPKIN ROBIN E.· SVP, Gen Counsel and Secrty. | Option exercise | 1,276 | $51.51 | $65,726.76 | filing |
| 2025-11-14 | MINICUCCI JAMES P.· SVP and GM, Personal Care | Option exercise | 1,225 | $51.51 | $63,099.75 | filing |
| 2025-11-14 | MUSA OSAMA M· SVP and CTO | Tax withholding | 717 | $51.51 | $36,932.67 | filing |
| 2025-11-14 | Drury Eileen· SVP and Chief HRO | Tax withholding | 603 | $51.51 | $31,060.53 | filing |
| 2025-11-14 | MINICUCCI JAMES P.· SVP and GM, Personal Care | Tax withholding | 383 | $51.51 | $19,728.33 | filing |
| 2025-11-14 | LAMPKIN ROBIN E.· SVP, Gen Counsel and Secrty. | Tax withholding | 381 | $51.51 | $19,625.31 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.